Ming-Lung Yu Selected Research

Insulin Resistance

10/2023	Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.
11/2017	Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase.
5/2015	Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
2/2013	Glucose abnormalities in hepatitis C virus infection.
1/2013	Host factors determining the efficacy of hepatitis C treatment.
9/2011	Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.
9/2011	Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women.
3/2010	Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
2/2010	Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues.
1/2010	Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Lung Yu Research Topics

Disease

133	Chronic Hepatitis C 04/2024 - 01/2002
120	Infections 03/2024 - 01/2002
75	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 04/2005
74	Fibrosis (Cirrhosis) 04/2024 - 03/2002
46	Chronic Hepatitis B 04/2024 - 02/2006
32	Hepatitis C 01/2024 - 02/2006
31	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 03/2002
28	Neoplasms (Cancer) 04/2024 - 02/2006
23	Hepatitis B 09/2023 - 02/2009
17	Liver Diseases (Liver Disease) 05/2024 - 01/2007
16	Viremia 01/2022 - 01/2002
15	Non-alcoholic Fatty Liver Disease 04/2024 - 09/2008
11	Insulin Resistance 10/2023 - 04/2009
11	Hepatitis 01/2023 - 06/2007
9	Coinfection 10/2023 - 10/2004
8	Body Weight (Weight, Body) 04/2024 - 02/2006
8	Fatty Liver 10/2023 - 12/2007
8	Chronic Renal Insufficiency 10/2023 - 03/2019
7	Obesity 10/2023 - 12/2007
7	Virus Diseases (Viral Diseases) 02/2022 - 07/2003
6	Liver Neoplasms (Liver Cancer) 04/2024 - 07/2013
6	Diabetes Mellitus 04/2024 - 09/2012
6	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2008
6	Hypertension (High Blood Pressure) 10/2023 - 12/2007
6	HIV Infections (HIV Infection) 01/2023 - 01/2014
5	COVID-19 02/2024 - 01/2020
4	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2021
4	Disease Progression 01/2022 - 06/2017
3	Overweight 10/2023 - 11/2007
3	Inflammation (Inflammations) 10/2021 - 03/2008
3	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

90	Antiviral Agents (Antivirals)IBA 04/2024 - 08/2009
62	Ribavirin (Virazole)FDA LinkGeneric 10/2023 - 10/2004
55	InterferonsIBA 01/2022 - 07/2003
39	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2002
27	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2023 - 09/2003
21	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2002
19	Interferon-alpha (Interferon Alfa)IBA 04/2021 - 01/2002
18	Alanine Transaminase (SGPT)IBA 10/2023 - 01/2002
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2007
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 05/2011
13	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 12/2007
11	Triglycerides (Triacylglycerol)IBA 10/2023 - 07/2006
11	Hepatitis B e AntigensIBA 07/2022 - 01/2007
10	entecavir FDA Link 03/2024 - 11/2016
9	Tenofovir (Viread)FDA Link 04/2024 - 01/2020
8	nasIBA 04/2024 - 07/2012
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 02/2015
7	SofosbuvirIBA 01/2024 - 03/2016
7	Uric Acid (Urate)IBA 03/2020 - 09/2008
7	Fetal Proteins (Fetoprotein)IBA 01/2020 - 04/2013
6	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
6	Transaminases (Aminotransferases)IBA 04/2024 - 06/2003
6	LipidsIBA 10/2023 - 07/2008
6	Insulin (Novolin)FDA Link 10/2023 - 01/2010
6	Sorafenib (BAY 43-9006)FDA Link 09/2022 - 10/2019
6	CytokinesIBA 01/2022 - 03/2008
6	asunaprevirIBA 01/2021 - 12/2017
6	daclatasvirIBA 01/2021 - 12/2017
6	Lamivudine (Epivir)FDA Link 11/2016 - 12/2006
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 06/2003
5	NucleosidesIBA 10/2023 - 11/2020
5	NucleotidesIBA 10/2023 - 11/2020
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2022 - 01/2011
5	Carrier Proteins (Binding Protein)IBA 03/2022 - 08/2017
5	peginterferon alfa-2a (Pegasys)FDA Link 12/2020 - 02/2009
5	micaIBA 01/2019 - 12/2015
5	CholesterolIBA 03/2016 - 07/2008
4	tenofovir alafenamideIBA 04/2024 - 07/2022
4	VaccinesIBA 02/2024 - 03/2009
4	velpatasvirIBA 01/2024 - 12/2018
4	Hemoglobins (Hemoglobin)IBA 01/2024 - 04/2017
4	Surface Antigens (Surface Antigen)IBA 11/2023 - 06/2007
4	AlbuminsIBA 10/2023 - 01/2020
4	BilirubinIBA 01/2022 - 10/2019
4	AntigensIBA 01/2022 - 11/2016
4	Phospholipases (Phospholipase)IBA 03/2016 - 03/2015
3	EnzymesIBA 05/2024 - 04/2010
3	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 11/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 04/2016
3	MicroRNAs (MicroRNA)IBA 03/2024 - 05/2014
3	oxidized low density lipoproteinIBA 10/2023 - 05/2015
3	TransferasesIBA 10/2023 - 07/2014
3	Colchicine FDA LinkGeneric 10/2023 - 07/2021
3	wisteria lectinIBA 03/2022 - 08/2017
3	Pioglitazone (Actos)FDA Link 10/2021 - 09/2008
3	Long Noncoding RNAIBA 01/2021 - 01/2019
3	Indicators and Reagents (Reagents)IBA 01/2021 - 03/2002
3	ombitasvirIBA 12/2018 - 11/2016
3	paritaprevirIBA 12/2018 - 11/2016
3	Ritonavir (Norvir)FDA Link 12/2018 - 11/2016
3	dasabuvirIBA 12/2018 - 11/2016
3	InterleukinsIBA 03/2018 - 01/2013
3	Serum AlbuminIBA 01/2015 - 11/2007

Therapy/Procedure

121	Therapeutics 04/2024 - 01/2002
10	Renal Dialysis (Hemodialysis) 01/2023 - 02/2002
9	Liver Transplantation 01/2021 - 01/2007
4	Drug Therapy (Chemotherapy) 02/2022 - 02/2006
3	Aftercare (After-Treatment) 03/2020 - 02/2009
3	Blood Transfusion (Blood Transfusions) 03/2019 - 01/2002